By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market Tuesday that its first-quarter revenues increased 7 percent year over year, led by its Clinical Diagnostics segment.

The Hercules, Calif.-based firm had total revenues of $485.1 million for the three-month period ended March 31, compared to $454.2 million for Q1 2010. On a currency-neutral basis, its revenues increased 5 percent. Bio-Rad beat analysts' consensus estimate for revenues of $482.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.